Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) SHH

Currency In CNY

AD

Valuation

Market Cap70.1B
Enterprise Value97.44B
P/E Ratio17.85
PEG Ratio0.89
Price/Sales Ratio1.47
Price/Book Ratio1.27
Enterprise/Revenue2.1
Enterprise/EBITDA11.96

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.08
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue41.5B
Revenue/Share16.04
Gross Profit19.12B
EBITDA9.99B
Net Income3.37B
Diluted EPS1.27

Balance Sheet

Total Cash15.29B
Total Cash/Share5.8
Total Debt39.91B
Total Debt/Equity0.81
Current Ratio0.93
Book Value Per Share24.13

Price History

52-Week Change-16.04
52-Week High33.1
52-Week Low20.85
Moving Average 50 Days23.24
Moving Average 200 Days25.37

Statistics

Average Volume29.49M
Shares Outstanding2.64B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.39
Trailing Annual Dividend Yield1.66
Payout Ratio0.4
Last Split Factor3:2
Last Split DateJuly 26, 2010
AD